Innovative method could address a major limitation in fluorescence microscopy
26 November 2024
With fluorescence imaging an essential tool in noninvasive biomedical research, the microscopy advancement holds opportunity for progress in optical imaging, according to the paper.
Virtual Patients, Real Results: How Digital Twins Are Reshaping Drug Development
26 November 2024
Aitia Bio’s Colin Hill, writing in the November 2024 issue of DIA’s Global Forum magazine outlines why “digital twins” – virtual models of patients, systems, or devices that simulate real-world data to predict outcomes, optimize treatments, and improve patient care – have the potential to reshape the entire drug development process.
news Innovating LNP design to improve mRNA therapeutics
25 November 2024
The new approach involving refinement and optimisation of ionisable lipids could accelerate the development of mRNA therapies, research suggests.
Siberian State Medical University and Skoltech to start production of bone tissue fillers
25 November 2024
By the end of 2025, the Siberian State Medical University and the Skolkovo Institute of Science and Technology (Skoltech) will establish a joint venture aimed at producing fillers specifically designed to repair defects in bone tissue.
Innovative method could address a major limitation in fluorescence microscopy
22 November 2024
With fluorescence imaging an essential tool in noninvasive biomedical research, the microscopy advancement holds opportunity for progress in optical imaging, according to the paper.
Siberian State Medical University and Skoltech to start production of bone tissue fillers
22 November 2024
By the end of 2025, the Siberian State Medical University and the Skolkovo Institute of Science and Technology (Skoltech) will establish a joint venture aimed at producing fillers specifically designed to repair defects in bone tissue.
Sechenov University is creating a digital drug reference book
21 November 2024
Sechenov University is developing an electronic catalog containing information about the effects of drugs. This system is expertly crafted to give medical professionals swift access to comprehensive drug information, enabling them to make informed comparisons.
Skills shortage still holding back pharma's digital transformation: survey
21 November 2024
The people piece of pharma’s digital transformation remains a problem. That is the top takeaway from a GlobalData survey, which showed companies are continuing to grapple with a skills shortage—and found bigger businesses are bearing the brunt of the problem.
Trials for Russia’s first CAR-T drug “Utzhefra” have started
20 November 2024
Clinical trials of the first Russian-developed CAR-T drug called Utzhefra (hemagenlecleucel) have started in Russia. Developed by experts at the National Medical Research Center of Hematology, this treatment targets severe cases of oncohematological diseases, specifically addressing resistant forms and relapses of B-cell malignant blood tumors. Only one CAR-T drug, Kimraya (tisagenlecleucel) by Novartis, is registered in Russia, approved in 2023 for treating specific cancers, costing around 39 million rubles.
Russian regions will get 5.5 billion rubles to fight diabetes
20 November 2024
Russian Prime Minister Mikhail Mishustin has signed four directives focused on funding initiatives aimed at combating diabetes. A total of 4.2 billion rubles will be allocated across 53 regions to establish and upgrade endocrinology centers and educational institutions dedicated to diabetes management. It is planned to open 1,127 health schools for adult patients and 124 for children.
05 November 2024
03 November 2024
October 10 – World Mental Health Day
10 October 2024
Innovative method could address a major limitation in fluorescence microscopy
26 November 2024
Virtual Patients, Real Results: How Digital Twins Are Reshaping Drug Development
26 November 2024
news Innovating LNP design to improve mRNA therapeutics
25 November 2024
Siberian State Medical University and Skoltech to start production of bone tissue fillers
25 November 2024